Literature DB >> 6470859

Long-term prospective study in children after respiratory syncytial virus infection.

C B Hall, W J Hall, C L Gala, F B MaGill, J P Leddy.   

Abstract

We have prospectively evaluated for the past 8 years 29 children who were hospitalized during infancy with acute lower respiratory tract illness caused by respiratory syncytial virus (RSV). No differences in the prevalence of a family history of atopy or breast-feeding in these infants compared with controls were noted. However, a history of parental smoking was significantly associated with hospital admission for RSV lower respiratory tract disease. Evidence of atopy, as defined by serum IgE levels and radioallergosorbent testing, have developed in only three (10%) of 29 children. Six children (21%) continue to have recurrent lower respiratory tract disease. Fifty-five percent of these children had abnormally low oxyhemoglobin levels (SaO2) measured by ear oximetry for the first 3 to 4 years after the acute illness. Twenty-one percent have persistently low SaO2 levels during the eighth year of follow-up. Spirometric values indicate evidence of peripheral airway obstruction. These studies suggest that an association between RSV lower respiratory tract infections and chronic abnormalities of pulmonary function may be detected sequentially through the first 8 years of life. These abnormalities are not limited to those children developing an atopic state during that same time period.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6470859     DOI: 10.1016/s0022-3476(84)80005-0

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  36 in total

1.  Characterization of intestinal dendritic cells in murine norovirus infection.

Authors:  Xiuxu Chen; Daniel Leach; Desiré A Hunter; Daniel Sanfelippo; Erika J Buell; Sarah J Zemple; Mitchell H Grayson
Journal:  Open Immunol J       Date:  2011

Review 2.  The respiratory syncitial virus and its role in acute bronchiolitis.

Authors:  M L Everard; A D Milner
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

3.  Cigarette smoke condensate enhances respiratory syncytial virus-induced chemokine release by modulating NF-kappa B and interferon regulatory factor activation.

Authors:  Shawn Monique Castro; Deepthi Kolli; Antonieta Guerrero-Plata; Roberto P Garofalo; Antonella Casola
Journal:  Toxicol Sci       Date:  2008-08-22       Impact factor: 4.849

Review 4.  Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients.

Authors:  S Samuel Weigt; Aric L Gregson; Jane C Deng; Joseph P Lynch; John A Belperio
Journal:  Semin Respir Crit Care Med       Date:  2011-08-19       Impact factor: 3.119

5.  Respiratory status and allergy nine to 10 years after acute bronchiolitis.

Authors:  V Noble; M Murray; M S Webb; J Alexander; A S Swarbrick; A D Milner
Journal:  Arch Dis Child       Date:  1997-04       Impact factor: 3.791

6.  Cell-specific expression of RANTES, MCP-1, and MIP-1alpha by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus.

Authors:  B Olszewska-Pazdrak; A Casola; T Saito; R Alam; S E Crowe; F Mei; P L Ogra; R P Garofalo
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

7. 

Authors:  François Freymuth; Geneviève Eugène; Jacques Brouard; Astrid Vabret; Joëlle Petitjean; Françoise Bonnin
Journal:  Ann Inst Pasteur Actual       Date:  2000-04-05

8.  Respiratory syncytial virus triggered adult respiratory distress syndrome in infants: a report of two cases.

Authors:  D C Bachmann; J Pfenninger
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

9.  Lung function, airway responsiveness, and respiratory symptoms before and after bronchiolitis.

Authors:  S Young; P T O'Keeffe; J Arnott; L I Landau
Journal:  Arch Dis Child       Date:  1995-01       Impact factor: 3.791

Review 10.  Epidemiologic, experimental, and clinical links between respiratory syncytial virus infection and asthma.

Authors:  Shyam S Mohapatra; Sandhya Boyapalle
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.